AKT1 and cancer: Being one of the most frequently disrupted tumor suppressors in cancer, a mutation in the phosphatase and tensin homolog deleted on chromosome 10 (PTEN), the natural antagonist of PI3K, relieves the repression of the PI3K/Akt signaling axis in PDAC.